Entity Details

Primary name IL1RN
Entity type gene
Source Source Link

Details

PrimaryID3557
RefseqGeneNG_021240
SymbolIL1RN
Nameinterleukin 1 receptor antagonist
Chromosome2
Location2q14.1
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-19
ModificationDate2021-06-20

Ontological Relatives

UniProt IDsIL1RA_HUMAN

GO terms

Show/Hide Table
GOName
GO:0002437 inflammatory response to antigenic stimulus
GO:0005125 cytokine activity
GO:0005149 interleukin-1 receptor binding
GO:0005150 interleukin-1, type I receptor binding
GO:0005151 interleukin-1, type II receptor binding
GO:0005152 interleukin-1 receptor antagonist activity
GO:0005615 extracellular space
GO:0005737 cytoplasm
GO:0005886 plasma membrane
GO:0006629 lipid metabolic process
GO:0006953 acute-phase response
GO:0006954 inflammatory response
GO:0006955 immune response
GO:0019221 cytokine-mediated signaling pathway
GO:0030073 insulin secretion
GO:0034115 negative regulation of heterotypic cell-cell adhesion
GO:0045352 interleukin-1 type I receptor antagonist activity
GO:0045353 interleukin-1 type II receptor antagonist activity
GO:0051384 response to glucocorticoid
GO:0070062 extracellular exosome
GO:0070498 interleukin-1-mediated signaling pathway
GO:2000660 negative regulation of interleukin-1-mediated signaling pathway

Diseases

Show/Hide Table
Disease IDSourceNameDescription
612852 OMIMInterleukin 1 receptor antagonist deficiency (DIRA)A rare autoinflammatory disease of skin and bone resulting in sterile multifocal osteomyelitis, periostitis, and pustulosis from birth. The term autoinflammatory disease describes a group of disorders characterized by attacks of seemingly unprovoked inflammation without significant levels of autoantibodies and autoreactive T-cells. The disease is caused by variants affecting the gene represented in this entry.
612628 OMIMMicrovascular complications of diabetes 4 (MVCD4)Pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis. Disease susceptibility is associated with variants affecting the gene represented in this entry.